QA: ENZO Biochem INC in us_health_services/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000316253_2024_ENZO_Biochem_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.4775010320627494, 'aggregate_val': 45564000, 'exp_sum': 87204000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 17275000, 'GeneralAndAdministrativeExpense': 21723000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 44272000, 'DepreciationDepletionAndAmortization': 0, 'SellingAndMarketingExpense': 0, 'ResearchAndDevelopmentExpense': 2642000, 'remainder_Expenses': 1292000}}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Expenses', 'missing_ratio': 0.4577164647824136, 'aggregate_val': 58020000, 'exp_sum': 106992000, 'exp_to_value': {'LaborExpense': 0, 'CostOfGoodsAndServicesSold': 17866000, 'GeneralAndAdministrativeExpense': 27202000, 'GoodwillImpairmentLoss': 0, 'OperatingCostsAndExpenses': 55797000, 'DepreciationDepletionAndAmortization': 0, 'SellingAndMarketingExpense': 0, 'ResearchAndDevelopmentExpense': 3904000, 'remainder_Expenses': 2223000}}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000316253')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000316253, ENZO Biochem INC

  xvar xval
0 IntangibleAssets 0
1 AssetsNonCurrent 9,371,000
2 AssetsCurrent 98,456,000
3 PropertyPlantAndEquipment 13,086,000
4 remainder_Assets 967,000
5 LongTermLiabilities 3,429,000
6 LiabilitiesCurrent 39,989,000
7 remainder_Liabilities 0
8 LaborExpense 0
9 CostOfGoodsAndServicesSold 17,866,000
10 GeneralAndAdministrativeExpense 27,202,000
11 GoodwillImpairmentLoss 0
12 OperatingCostsAndExpenses 55,797,000
13 DepreciationDepletionAndAmortization 0
14 SellingAndMarketingExpense 0
15 ResearchAndDevelopmentExpense 3,904,000
16 remainder_Expenses -46,749,000
17 remainder_Revenues 31,061,000
18 remainder_NetIncome 47,247,000
19 remainder_ComprehensiveNetIncome -1,273,000
  yvar yval
0 Assets 121,880,000
1 Liabilities 43,418,000
2 Expenses 58,020,000
3 Revenues 31,061,000
4 StockholdersEquity 78,462,000
5 NetIncome 20,288,000
6 ComprehensiveNetIncome 19,015,000
7 BaseVar 151,449,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.61
9 EconomicCapitalRatio 2.12

Edgar->Model Mapping

Feature Distribution

Change over Time